Ding Lei, Zhang Shuhong, Chen Shijun, Zheng Lixue, Xiao Lianxiang
Department of Infectious Diseases, Jinan Central Hospital Affiliated to Shandong University, Jinan, China.
Department of infectious diseases, Jinan Infectious Diseases Hospital Affiliated to Shandong University, Jinan, China.
J Cell Biochem. 2019 May;120(5):8352-8358. doi: 10.1002/jcb.28119. Epub 2018 Dec 11.
This study aimed to investigate the role and mechanism of action of targeting protein for Xklp2 (TPX2) in liver cancer, we compared TPX messenger RNA (mRNA) expression in liver cancer tissue samples and adjacent normal liver tissue samples as well as in human liver cancer cell lines and nonmalignant cell line by quantitative reverse transcription polymerase chain reaction (qRT-PCR). TPX2 gene was silenced in HepG2 cells by transfection with the lentiviral vector expressing TPX2-targeting short hairpin RNA (shRNA), and the knockdown efficiency was evaluated by RT-qPCR. Cell proliferation, apoptosis as well as protein level of c-Myc, cyclin D1, caspase-3, phosphorylated glycogen synthase kinase-3β (p-GSK-3β), and β-catenin in HepG2 cells were evaluated before and after the TPX2 knockdown. Wnt/β-catenin signaling pathway was inhibited by treatment with 20 μM of XAV-939 or activated by treatment with 20 mM of LiCl. We found that TPX2 mRNA level was significantly increased in liver cancer tissue samples and cell lines comparing to noncancerous counterparts (P < 0.05). TPX2 knockdown significantly reduces TPX2 expression (P < 0.01), cell proliferation (P < 0.05), protein level of c-Myc and cyclin D1 (P < 0.01), activation of Wnt/β-catenin signaling in HepG2 cells (P < 0.01) while increasing cell apoptosis (P < 0.01). Treatment with XAV-939 significantly reduced HepG2 cell proliferation (P < 0.05) while increasing cell apoptosis (P < 0.01). Treatment with LiCl significantly attenuated the antiproliferative and apoptosis-promoting effect of TPX2 knockdown on HepG2 cells (P < 0.05). Lentivirus-mediated silencing of TPX2 gene could inhibit proliferation and induce apoptosis in hepatoma cells by inhibiting Wnt signaling pathway and regulating cyclin and apoptosis-related proteins.
本研究旨在探讨靶向Xklp2蛋白(TPX2)在肝癌中的作用及作用机制,我们通过定量逆转录聚合酶链反应(qRT-PCR)比较了肝癌组织样本和相邻正常肝组织样本以及人肝癌细胞系和非恶性细胞系中TPX信使核糖核酸(mRNA)的表达。通过转染表达靶向TPX2的短发夹RNA(shRNA)的慢病毒载体使HepG2细胞中的TPX2基因沉默,并通过RT-qPCR评估敲低效率。在TPX2敲低前后评估HepG2细胞的增殖、凋亡以及c-Myc、细胞周期蛋白D1、半胱天冬酶-3、磷酸化糖原合酶激酶-3β(p-GSK-3β)和β-连环蛋白的蛋白水平。用20μM的XAV-939处理抑制Wnt/β-连环蛋白信号通路,用20mM的LiCl处理激活该信号通路。我们发现,与非癌对应物相比,肝癌组织样本和细胞系中TPX2 mRNA水平显著升高(P<0.05)。TPX2敲低显著降低TPX2表达(P<0.01)、细胞增殖(P<0.05)、c-Myc和细胞周期蛋白D1的蛋白水平(P<0.01),抑制HepG2细胞中Wnt/β-连环蛋白信号通路的激活(P<0.01),同时增加细胞凋亡(P<0.01)。用XAV-939处理显著降低HepG2细胞增殖(P<0.05),同时增加细胞凋亡(P<0.01)。用LiCl处理显著减弱TPX2敲低对HepG2细胞的抗增殖和促凋亡作用(P<0.05)。慢病毒介导的TPX2基因沉默可通过抑制Wnt信号通路和调节细胞周期蛋白及凋亡相关蛋白来抑制肝癌细胞增殖并诱导其凋亡。